BG Bunge Global SA
Fats & Oils · NYSE · SEC CIK 1996862 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY55.5%
TTM net income YoY-12.4%
TTM EPS YoY-36.0%
Revenue 3-yr CAGR15.1%
Net income 3-yr CAGR-16.1%
Margins
Gross margin5.1%
Operating margin—
Net margin1.2%
FCF margin-2.8%
EBITDA margin—
Returns
ROE7.2%
ROA2.4%
ROIC (approx.)—
Asset turnover1.95x
Leverage & solvency
Liabilities / assets64.0%
Debt / equity1.03x
Current ratio1.50x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-0.82x
Accruals ratio4.4%
Payout ratio47.4%
Capex / revenue1.8%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q42025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q42024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $23.80B | $24.04B | $21.86B | $23.76B | $22.16B | $12.77B | $11.64B | $13.54B |
| Cost of revenue | $22.47B | $22.36B | $21.09B | $22.75B | $21.09B | $12.03B | $11.05B | $12.46B |
| Gross profit | $1.33B | $1.68B | $766.00M | $1.01B | $1.06B | $738.00M | $597.00M | $1.08B |
| SG&A expense | $605.00M | $606.00M | $531.00M | $637.00M | $678.00M | $418.00M | $380.00M | $451.00M |
| Interest expense | $208.00M | $197.00M | $181.00M | $216.00M | $202.00M | $106.00M | $104.00M | $113.00M |
| Pretax income | $515.00M | $943.00M | $61.00M | $86.00M | $270.00M | $494.00M | $284.00M | $730.00M |
| Income tax | $168.00M | $236.00M | -$14.00M | -$2.00M | $86.00M | $124.00M | $80.00M | $100.00M |
| Net income | $318.00M | $678.00M | $68.00M | $95.00M | $166.00M | $354.00M | $201.00M | $602.00M |
| EPS (basic) | 1.65 | 3.50 | 0.35 | 0.49 | 0.84 | 2.63 | 1.50 | 4.41 |
| EPS (diluted) | 1.64 | 3.47 | 0.35 | 0.49 | 0.84 | 2.61 | 1.48 | 4.36 |
| Dividends declared per share | 0.72 | 2.88 | 0.70 | 0.70 | 2.80 | 2.80 | 0.68 | 0.68 |
| Weighted avg. shares (diluted) | 194.05M | 195.34M | 195.73M | — | 198.48M | 135.60M | 135.41M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $524.00M | $593.00M | $839.00M | $1.14B | $1.31B | $6.79B | $3.25B | $3.33B |
| Short-term investments | $366.00M | $195.00M | $760.00M | $861.00M | $1.85B | $347.00M | $638.00M | $484.00M |
| Receivables | $4.14B | $3.93B | $3.98B | $3.87B | $3.49B | $2.26B | $2.33B | $2.15B |
| Inventory | $16.62B | $15.46B | $15.43B | $13.20B | $13.31B | $8.01B | $7.82B | $6.49B |
| Current assets | $29.21B | $26.21B | $27.09B | $24.39B | $26.72B | $21.45B | $17.37B | $15.96B |
| PP&E, net | $11.94B | $11.95B | $11.88B | $11.68B | $11.55B | $5.83B | $5.51B | $5.25B |
| Goodwill | $3.37B | $3.35B | $3.29B | $3.14B | $2.77B | $460.00M | $463.00M | $453.00M |
| Intangibles | $278.00M | $288.00M | $304.00M | $309.00M | $328.00M | $316.00M | $319.00M | $321.00M |
| Total assets | $49.66B | $46.78B | $47.58B | $44.53B | $46.30B | $31.15B | $26.66B | $24.90B |
| Current liabilities | $19.43B | $16.73B | $16.94B | $15.13B | $16.10B | $10.38B | $8.54B | $7.43B |
| Short-term debt | $7.80B | $5.79B | $4.61B | $5.22B | $5.78B | $4.22B | $2.00B | $1.54B |
| Long-term debt | $8.94B | $9.43B | $9.95B | $8.83B | $9.81B | $7.04B | $4.71B | $4.69B |
| Total debt | $16.75B | $15.21B | $14.55B | $14.05B | $15.59B | $11.27B | $6.72B | $6.24B |
| Total liabilities | $31.78B | $29.37B | $30.10B | $27.11B | $29.01B | $19.20B | $15.07B | $13.95B |
| Shareholders' equity | $16.30B | $15.95B | $16.05B | $15.90B | $15.77B | $10.88B | $10.58B | $9.91B |
| Net debt | $16.22B | $14.62B | $13.71B | $12.92B | $14.27B | $4.48B | $3.47B | $2.91B |
| Cash flow statement | ||||||||
| Operating cash flow | -$1.18B | -$585.00M | -$541.00M | $1.35B | $854.00M | -$1.07B | -$285.00M | $1.05B |
| Capital expenditure | $384.00M | $443.00M | $336.00M | $538.00M | $469.00M | $406.00M | $310.00M | $489.00M |
| Free cash flow | -$1.56B | -$1.03B | -$877.00M | $809.00M | $385.00M | -$1.48B | -$595.00M | $564.00M |
| Investing cash flow | -$565.00M | -$93.00M | -$182.00M | $297.00M | -$5.42B | $178.00M | -$280.00M | -$157.00M |
| Financing cash flow | $1.71B | $426.00M | $406.00M | -$1.79B | -$917.00M | $4.45B | $490.00M | -$466.00M |
| Depreciation & amortization | $248.00M | $256.00M | $238.00M | $226.00M | $241.00M | $116.00M | $120.00M | $123.00M |
| Stock-based compensation | $17.00M | $30.00M | $23.00M | $19.00M | $19.00M | $16.00M | $19.00M | $16.00M |
| Dividends paid | $139.00M | $139.00M | $136.00M | $135.00M | $139.00M | $94.00M | $91.00M | $91.00M |
Free plan shows the latest 8 periods; Pro shows all 19 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.